{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T00:11:39Z","timestamp":1788567099452,"version":"build-2803163510"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2025,5,16]],"date-time":"2025-05-16T00:00:00Z","timestamp":1747353600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,5,16]],"date-time":"2025-05-16T00:00:00Z","timestamp":1747353600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001782","name":"University of Melbourne","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001782","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cancer Res Clin Oncol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>Chemotherapy administration is a balancing act between giving enough to achieve the desired tumour response while limiting adverse effects. Chemotherapy dosing is based on body surface area (BSA). Emerging evidence suggests body composition plays a crucial role in the pharmacokinetic and pharmacodynamic profile of cytotoxic agents and could inform optimal dosing. This study aims to assess how lumbosacral body composition influences adverse events in patients receiving neoadjuvant chemotherapy for rectal cancer.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A retrospective study (February 2013 to March 2023) examined the impact of body composition on neoadjuvant treatment outcomes for rectal cancer patients. Staging CT scans were analysed using a validated AI model to measure lumbosacral skeletal muscle (SM), intramuscular adipose tissue (IMAT), visceral adipose tissue (VAT), and subcutaneous adipose tissue volume and density. Multivariate analyses explored the relationship between body composition and chemotherapy outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      242 patients were included (164 males, 78 Females), median age 63.4 years. Chemotherapy dose reductions occurred more frequently in females (26.9% vs. 15.9%,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.042) and in females with greater VAT density (-82.7 vs. -89.1,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.007) and SM: IMAT\u2009+\u2009VAT volume ratio (1.99 vs. 1.36,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.042). BSA was a poor predictor of dose reduction (AUC 0.397, sensitivity 38%, specificity 60%) for female patients, whereas the SM: IMAT\u2009+\u2009VAT volume ratio (AUC 0.651, sensitivity 76%, specificity 61%) and VAT density (AUC 0.699, sensitivity 57%, specificity 74%) showed greater predictive ability. Body composition didn\u2019t influence dose adjustment of male patients.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Lumbosacral body composition outperformed BSA in predicting adverse events in female patients with rectal cancer undergoing neoadjuvant chemotherapy.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s00432-025-06219-5","type":"journal-article","created":{"date-parts":[[2025,5,16]],"date-time":"2025-05-16T12:57:34Z","timestamp":1747400254000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Artificial intelligence generated 3D body composition predicts dose modifications in patients undergoing neoadjuvant chemotherapy for rectal cancer"],"prefix":"10.1007","volume":"151","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9134-7509","authenticated-orcid":false,"given":"Alex","family":"Besson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Mardinli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lara","family":"Wirth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josephine","family":"Yeung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rory","family":"Kokelaar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Gibbs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fiona","family":"Reid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin M.","family":"Yeung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,16]]},"reference":[{"key":"6219_CR1","doi-asserted-by":"crossref","unstructured":"Ali R, Baracos VE, Sawyer MB, Bianchi L, Roberts S, Assenat E, Mollevi C, and Pierre Senesse (2016). \u2018Lean body mass as an independent determinant of dose-limiting toxicityneuropathy in patients with colon cancer treated with FOLFOX regimens\u2019, Cancer medicine, 5: 607\u2013\u200916","DOI":"10.1002\/cam4.621"},{"key":"6219_CR2","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1002\/(SICI)1097-0142(20000215)88:4<796::AID-CNCR10>3.0.CO;2-P","volume":"88","author":"A Aslani","year":"2000","unstructured":"Aslani A, Smith RC, Barry J, Allen N, Pavlakis, John AL (2000) The predictive value of body protein for chemotherapy-induced toxicity. Cancer 88:796\u2013803","journal-title":"Cancer"},{"key":"6219_CR3","doi-asserted-by":"publisher","first-page":"101204","DOI":"10.1016\/j.esmoop.2023.101204","volume":"8","author":"I Baraibar","year":"2023","unstructured":"Baraibar I, Ros J, Saoudi N, Salv\u00e0 F, Garc\u00eda A, Castells MR, Tabernero J, \u00c9lez E (2023) Sex and gender perspectives in colorectal cancer. ESMO Open 8:101204","journal-title":"ESMO Open"},{"key":"6219_CR4","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/j.clcc.2024.06.001","volume":"23","author":"S Bedrikovetski","year":"2024","unstructured":"Bedrikovetski S, Traeger L, Seow W, Dudi-Venkata NN, Selva-Nayagam S, Penniment M, Sammour T (2024) Oncological outcomes and response rate after total neoadjuvant therapy for locally advanced rectal cancer: A network Meta-Analysis comparing induction vs. Consolidation chemotherapy vs. Standard chemoradiation. Clin Colorectal Cancer 23:326\u201336e9","journal-title":"Clin Colorectal Cancer"},{"key":"6219_CR5","doi-asserted-by":"publisher","first-page":"3411","DOI":"10.1007\/s00520-021-06025-y","volume":"29","author":"A Besson","year":"2021","unstructured":"Besson A, Deftereos I, Gough K, Taylor D, Shannon R, Justin MY (2021) The association between sarcopenia and quality of life in patients undergoing colorectal cancer surgery: an exploratory study. Support Care Cancer 29:3411\u20133420","journal-title":"Support Care Cancer"},{"key":"6219_CR6","doi-asserted-by":"crossref","unstructured":"Bredella MA (2017) \u2018Sex differences in body composition\u2019, Sex and gender factors affecting metabolic homeostasis, diabetes and obesity: 9\u201327","DOI":"10.1007\/978-3-319-70178-3_2"},{"key":"6219_CR7","doi-asserted-by":"publisher","first-page":"13915","DOI":"10.1007\/s00432-023-05227-7","volume":"149","author":"K Cao","year":"2023","unstructured":"Cao K, Yeung J, Arafat Y, CheukShan Choi MYK, Wei S, Chan M, Lee PN, Baird, Justin MCY (2023) Can AI-based body composition assessment outperform body surface area in predicting dose-limiting toxicities for colonic cancer patients on chemotherapy? J Cancer Res Clin Oncol 149:13915\u201313923","journal-title":"J Cancer Res Clin Oncol"},{"key":"6219_CR8","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1002\/jmrs.798","volume":"71","author":"K Cao","year":"2024","unstructured":"Cao K, Yeung J, Arafat Y, Qiao J, Gartrell R, Master M, Justin MC, Yeung, Paul NB (2024) Using a new artificial intelligence-aided method to assess body composition CT segmentation in colorectal cancer patients. J Med Radiat Sci 71:519\u2013528","journal-title":"J Med Radiat Sci"},{"key":"6219_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00520-024-09108-8","volume":"33","author":"K Cao","year":"2025","unstructured":"Cao K, Yeung J, Wei MYK, Choi CS, Lee M, Lim LJ, Arafat Y, Baird PN, Justin Yeung (2025) Improving the prediction of chemotherapy dose-limiting toxicity in colon cancer patients using an AI-CT-based 3D body composition of the entire L1\u2013L5 lumbar spine. Support Care Cancer 33:1\u20139","journal-title":"Support Care Cancer"},{"key":"6219_CR10","doi-asserted-by":"crossref","unstructured":"Charette N, Vandeputte C, Ameye L, Bogaert CV, Krygier J, Guiot T Am\u00e9lie Deleporte, Thierry Delaunoit, Karen Geboes, and Jean-Luc Van Laethem (2019). \u2018Prognostic value of adipose tissue and muscle mass in advanced colorectal cancer: a post hoc analysis of two non-randomized phase II trials\u2019. BMC Cancer, 19: 1\u20139","DOI":"10.1186\/s12885-019-5319-8"},{"key":"6219_CR11","doi-asserted-by":"publisher","first-page":"2607","DOI":"10.1016\/j.clnu.2022.09.016","volume":"41","author":"E Cheng","year":"2022","unstructured":"Cheng E, Caan BJ, Wendy Y, Chen ML, Irwin CM, Prado, Cespedes Feliciano (2022) Adipose tissue radiodensity and mortality among patients with nonmetastatic breast cancer. Clin Nutr 41:2607\u20132613","journal-title":"Clin Nutr"},{"key":"6219_CR12","doi-asserted-by":"publisher","first-page":"671547","DOI":"10.3389\/fnut.2021.671547","volume":"8","author":"D da Silva Dias","year":"2022","unstructured":"da Silva Dias D, Machado M, Trabulo C, Gos\u00e1lbez B, and Paula Ravasco (2022) Impact of body composition on prognosis and dose-limiting toxicities on metastatic colorectal cancer. Front Nutr 8:671547","journal-title":"Front Nutr"},{"key":"6219_CR13","doi-asserted-by":"publisher","first-page":"e540","DOI":"10.1016\/j.clon.2021.05.011","volume":"33","author":"I Drami","year":"2021","unstructured":"Drami I, Pring ET, Gould L, Malietzis G, Naghibi M, Athanasiou T, Glynne-Jones R, Jenkins JT (2021) Body composition and dose-limiting toxicity in colorectal cancer chemotherapy treatment; a systematic review of the literature. Could muscle mass be the new body surface area in chemotherapy dosing? Clin Oncol 33:e540\u2013e52","journal-title":"Clin Oncol"},{"key":"6219_CR14","doi-asserted-by":"crossref","unstructured":"Han CJ, Xia Ning CE, Burd DJ, Spakowicz F, Tounkara MF, Kalady AM, Noonan Susan McCabe, and Diane Von Ah (2024). \u2018Chemotoxicity and associated risk factors in colorectal cancer: a systematic review and meta-analysis\u2019. Cancers, 16: 2597","DOI":"10.3390\/cancers16142597"},{"key":"6219_CR15","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1002\/cpt.2069","volume":"109","author":"JE Knikman","year":"2021","unstructured":"Knikman JE, Hans Gelderblom, Jos H, Beijnen A, Cats H-J, Guchelaar, Linda MH (2021) Individualized dosing of fluoropyrimidine\u2010based chemotherapy to prevent severe fluoropyrimidine\u2010related toxicity: what are the options? Clin Pharmacol Ther 109:591\u2013604","journal-title":"Clin Pharmacol Ther"},{"key":"6219_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2165\/00003088-200038010-00001","volume":"38","author":"F L\u00e9vi","year":"2000","unstructured":"L\u00e9vi F, Metzger G\u00e9rard, Massari C, G\u00e9rard, Milano (2000) Oxaliplatin: pharmacokinetics and chronopharmacological aspects. Clin Pharmacokinet 38:1\u201321","journal-title":"Clin Pharmacokinet"},{"key":"6219_CR17","doi-asserted-by":"publisher","first-page":"101201","DOI":"10.1016\/j.esmoop.2023.101201","volume":"8","author":"M Li","year":"2023","unstructured":"Li M, Mindt S, L\u00fcck A, Hutzschenreuter U, Kollendt M, Lathan B, Z\u00f6ller T, Frank-Gleich S, Lorentz C, Lamberti C (2023) Drug monitoring detects under-and overdosing in patients receiving 5-fluorouracil-containing chemotherapy\u2014results of a prospective, multicenter German observational study. ESMO Open 8:101201","journal-title":"ESMO Open"},{"key":"6219_CR18","doi-asserted-by":"crossref","unstructured":"Li\u0219cu H-D, Antone-Iordache I-L, Atasiei D-I, Anghel IV, Ilie A-T, Emamgholivand T, Ionescu A-I Florica \u0218andru, Christopher Pavel, and Flavia Ultimescu (2024). \u2018The Impact on Survival of Neoadjuvant Treatment Interruptions in Locally Advanced Rectal Cancer Patients\u2019. J Personalized Med, 14: 266","DOI":"10.3390\/jpm14030266"},{"key":"6219_CR19","doi-asserted-by":"crossref","unstructured":"Pellegrini M, Besutti G, Ottone M, Canovi S, Bonelli E, Venturelli F, Far\u00ec R Angela Damato, Candida Bonelli, and Carmine Pinto (2023). \u2018Abdominal fat characteristics and mortality in rectal cancer: a retrospective study\u2019. Nutrients, 15:374","DOI":"10.3390\/nu15020374"},{"key":"6219_CR20","doi-asserted-by":"crossref","unstructured":"Port RE, Barbel Daniel RW, Ding, Herrmann R (1991) \u2018Relative importance of dose, body surface area, sex, and age for 5-fluorouracil clearance\u2019, Oncology, 48:277\u2013\u200981","DOI":"10.1159\/000226942"},{"key":"6219_CR22","doi-asserted-by":"crossref","unstructured":"Prado CMM, Jessica R, Lieffers, Linda J, McCargar T, Reiman MB, Sawyer L, Martin, Vickie EB (2008) \u2018Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study\u2019, The lancet oncology, 9: 629\u2013\u200935","DOI":"10.1016\/S1470-2045(08)70153-0"},{"key":"6219_CR21","doi-asserted-by":"publisher","first-page":"3264","DOI":"10.1158\/1078-0432.CCR-06-3067","volume":"13","author":"MM Prado, Carla","year":"2007","unstructured":"Prado, Carla MM, Vickie E, Baracos, Linda J, McCargar M, Mourtzakis KE, Mulder T, Reiman CA, Butts AG, Scarfe, Michael BS (2007) Body composition as an independent determinant of 5-fluorouracil\u2013based chemotherapy toxicity. Clin Cancer Res 13:3264\u20133268","journal-title":"Clin Cancer Res"},{"key":"6219_CR23","doi-asserted-by":"publisher","first-page":"4383","DOI":"10.3748\/wjg.v25.i31.4383","volume":"25","author":"AE Tuomisto","year":"2019","unstructured":"Tuomisto AE, Markus J, M\u00e4kinen, Juha PV\u00e4yrynen (2019) Systemic inflammation in colorectal cancer: underlying factors, effects, and prognostic significance. World J Gastroenterol 25:4383","journal-title":"World J Gastroenterol"},{"key":"6219_CR24","doi-asserted-by":"crossref","unstructured":"Walter V, Jansen L, Hoffmeister M, Ulrich A, Roth W Hendrik Bl\u00e4ker, Jenny Chang-Claude, and Hermann Brenner. 2016. \u2018Prognostic relevance of prediagnostic weight loss and overweight at diagnosis in patients with colorectal cancer\u2019. Am J Clin Nutr, 104: 1110\u20131120","DOI":"10.3945\/ajcn.116.136531"}],"container-title":["Journal of Cancer Research and Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-025-06219-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00432-025-06219-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-025-06219-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,10]],"date-time":"2025-06-10T06:32:33Z","timestamp":1749537153000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00432-025-06219-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,16]]},"references-count":24,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2025,5]]}},"alternative-id":["6219"],"URL":"https:\/\/doi.org\/10.1007\/s00432-025-06219-5","relation":{},"ISSN":["1432-1335"],"issn-type":[{"value":"1432-1335","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,16]]},"assertion":[{"value":"9 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authorship have no disclosures to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"168"}}